PROCANICARE Italien - italienska - Ministero della Salute

procanicare

ecuphar italia s.r.l. - lactobacillus fermentum ncimb 41636 + lactobacillus plantarum ncimb 41638 + lactobacillus rhamnosus ncimb 41640 (1a001) - orale - lactobacillus fermentum ncimb 41636 + lactobacillus plantarum ncimb 41638 + lactobacillus rhamnosus ncimb 41640 (1a001) - tutti gli altri prodotti non terapeutici - cani

PEMETREXED AUROBINDO Italien - italienska - AIFA (Agenzia Italiana del Farmaco)

pemetrexed aurobindo

aurobindo pharma (italia) s.r.l. - pemetrexed - pemetrexed

Pemetrexed Baxter Europeiska unionen - italienska - EMA (European Medicines Agency)

pemetrexed baxter

baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agenti antineoplastici - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.